Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy.

MLA

Smith, Neil R., et al. “Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 19, no. 24, Dec. 2013, pp. 6943–56. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-13-1637.

APA

Smith, N. R., Baker, D., Farren, M., Pommier, A., Swann, R., Wang, X., Mistry, S., McDaid, K., Kendrew, J., Womack, C., Wedge, S. R., & Barry, S. T. (2013). Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(24), 6943–6956. https://doi.org/10.1158/1078-0432.CCR-13-1637

Chicago

Smith, Neil R, Dawn Baker, Matthew Farren, Aurelien Pommier, Ruth Swann, Xin Wang, Sunita Mistry, et al. 2013. “Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 19 (24): 6943–56. doi:10.1158/1078-0432.CCR-13-1637.